1. Home
  2. RVMD vs TLN Comparison

RVMD vs TLN Comparison

Compare RVMD & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • TLN
  • Stock Information
  • Founded
  • RVMD 2014
  • TLN 2015
  • Country
  • RVMD United States
  • TLN United States
  • Employees
  • RVMD N/A
  • TLN N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • TLN Electric Utilities: Central
  • Sector
  • RVMD Health Care
  • TLN Utilities
  • Exchange
  • RVMD Nasdaq
  • TLN Nasdaq
  • Market Cap
  • RVMD 10.2B
  • TLN 9.2B
  • IPO Year
  • RVMD 2020
  • TLN N/A
  • Fundamental
  • Price
  • RVMD $56.86
  • TLN $220.70
  • Analyst Decision
  • RVMD Strong Buy
  • TLN Strong Buy
  • Analyst Count
  • RVMD 13
  • TLN 9
  • Target Price
  • RVMD $57.00
  • TLN $225.00
  • AVG Volume (30 Days)
  • RVMD 1.6M
  • TLN 1.2M
  • Earning Date
  • RVMD 11-06-2024
  • TLN 11-14-2024
  • Dividend Yield
  • RVMD N/A
  • TLN N/A
  • EPS Growth
  • RVMD N/A
  • TLN 15.92
  • EPS
  • RVMD N/A
  • TLN 10.60
  • Revenue
  • RVMD $742,000.00
  • TLN $2,060,000,000.00
  • Revenue This Year
  • RVMD N/A
  • TLN N/A
  • Revenue Next Year
  • RVMD $300.00
  • TLN $13.41
  • P/E Ratio
  • RVMD N/A
  • TLN $19.45
  • Revenue Growth
  • RVMD N/A
  • TLN 159.45
  • 52 Week Low
  • RVMD $20.86
  • TLN $53.95
  • 52 Week High
  • RVMD $62.40
  • TLN $221.14
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 61.89
  • TLN 62.46
  • Support Level
  • RVMD $53.69
  • TLN $200.00
  • Resistance Level
  • RVMD $62.40
  • TLN $221.14
  • Average True Range (ATR)
  • RVMD 2.10
  • TLN 13.10
  • MACD
  • RVMD -0.35
  • TLN 0.73
  • Stochastic Oscillator
  • RVMD 49.83
  • TLN 84.13

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About TLN Talen Energy Corporation Common Stock

Talen Energy Corp is an independent power producer and infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.

Share on Social Networks: